These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22237432)

  • 1. Incidence and predictors of positive and negative effects of BRCA1/2 genetic testing on familial relationships: a 3-year follow-up study.
    Lapointe J; Bouchard K; Patenaude AF; Maunsell E; Simard J; Dorval M
    Genet Med; 2012 Jan; 14(1):60-8. PubMed ID: 22237432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.
    Finlay E; Stopfer JE; Burlingame E; Evans KG; Nathanson KL; Weber BL; Armstrong K; Rebbeck TR; Domchek SM
    Genet Test; 2008 Mar; 12(1):81-91. PubMed ID: 18373407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
    van Oostrom I; Meijers-Heijboer H; Lodder LN; Duivenvoorden HJ; van Gool AR; Seynaeve C; van der Meer CA; Klijn JG; van Geel BN; Burger CW; Wladimiroff JW; Tibben A
    J Clin Oncol; 2003 Oct; 21(20):3867-74. PubMed ID: 14551306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
    J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
    Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).
    Lodder LN; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Seynaeve C; van Geel AN; Tilanus MM; Bartels CC; Verhoog LC; Brekelmans CT; Burger CW; Niermeijer MF
    Breast Cancer Res Treat; 2002 May; 73(2):97-112. PubMed ID: 12088120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
    Patenaude AF; Dorval M; DiGianni LS; Schneider KA; Chittenden A; Garber JE
    J Clin Oncol; 2006 Feb; 24(4):700-6. PubMed ID: 16446344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.
    Schwartz MD; Peshkin BN; Hughes C; Main D; Isaacs C; Lerman C
    J Clin Oncol; 2002 Jan; 20(2):514-20. PubMed ID: 11786581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
    Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns?
    Halbert CH; Stopfer JE; McDonald J; Weathers B; Collier A; Troxel AB; Domchek S
    J Clin Oncol; 2011 Nov; 29(32):4302-6. PubMed ID: 21990416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women receiving news of a family BRCA1/2 mutation: messages of fear and empowerment.
    Crotser CB; Dickerson SS
    J Nurs Scholarsh; 2010 Dec; 42(4):367-78. PubMed ID: 21091619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands.
    Himes DO; Gibbons DK; Birmingham WC; Beckstrand RL; Gammon A; Kinney AY; Clayton MF
    J Genet Couns; 2019 Oct; 28(5):950-961. PubMed ID: 31199558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships.
    McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
    Am J Med Genet A; 2005 Mar; 133A(2):165-9. PubMed ID: 15633195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening.
    Metcalfe KA; Mian N; Enmore M; Poll A; Llacuachaqui M; Nanda S; Sun P; Hughes KS; Narod SA
    Breast Cancer Res Treat; 2012 Jun; 133(2):735-40. PubMed ID: 22240989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiences of BRCA1/2 Gene Mutation-Positive Women With Cancer in Communicating Genetic Risk to Their Relatives.
    Seven M; Shah LL; Daack-Hirsch S; Yazici H
    Cancer Nurs; 2021 May-Jun 01; 44(3):E142-E150. PubMed ID: 32022782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Life after BRCA1/2 testing: family communication and support issues.
    DeMarco TA; McKinnon WC
    Breast Dis; 2006-2007; 27():127-36. PubMed ID: 17917144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit finding in response to BRCA1/2 testing.
    Low CA; Bower JE; Kwan L; Seldon J
    Ann Behav Med; 2008 Feb; 35(1):61-9. PubMed ID: 18347905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family communication about positive BRCA1 and BRCA2 genetic test results.
    McGivern B; Everett J; Yager GG; Baumiller RC; Hafertepen A; Saal HM
    Genet Med; 2004; 6(6):503-9. PubMed ID: 15545746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of the disclosure process and support needs of BRCA1 and BRCA2 carriers.
    Segal J; Esplen MJ; Toner B; Baedorf S; Narod S; Butler K
    Am J Med Genet A; 2004 Mar; 125A(3):267-72. PubMed ID: 14994235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.